SEC CIK 1350382
Ellison Marvin R
Reported ownership across 4 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| LOWview stock → | 260,460 | 2026-04-01 |
| HDview stock → | 182,902 | 2014-09-21 |
| HRBview stock → | 22,752.63 | 2013-09-12 |
| FDXview stock → | 11,806 | 2026-08-28 |
Position History — LOW
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — LOW
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-04-01 | Grant / award | 37,292 | $0.00 | 260,460 |
| 2026-04-01 | Tax withholding | 7,875 | $235.98 | 223,168 |
| 2026-01-09 | Open-market sale | 3,524 | $262.51 | 231,043 |
| 2026-01-09 | Open-market sale | 7,323 | $261.39 | 234,567 |
| 2026-01-09 | Open-market sale | 7,153 | $260.30 | 241,890 |
| 2025-08-20 | Open-market sale | 7,241 | $260.96 | 281,802 |
| 2025-08-20 | Open-market sale | 5,408 | $261.88 | 276,394 |
| 2025-08-20 | Open-market sale | 7,009 | $262.33 | 269,385 |
| 2025-08-20 | Open-market sale | 1,601 | $264.49 | 267,784 |
| 2025-08-20 | Open-market sale | 681 | $265.50 | 267,103 |
| 2025-08-20 | Open-market sale | 18,060 | $266.63 | 249,043 |
| 2025-04-01 | Grant / award (derivative) | 54,998 | $0.00 | 54,998 |
| 2025-04-01 | Option exercise (derivative) | 27,963 | $0.00 | 0 |
| 2025-04-01 | Tax withholding | 18,873 | $234.01 | 270,827 |
| 2025-04-01 | Option exercise | 27,963 | $0.00 | 289,700 |
| 2025-04-01 | Grant / award | 18,216 | $0.00 | 289,043 |
| 2025-03-20 | Grant / award (derivative) | 27,963 | $0.00 | 27,963 |
| 2024-04-01 | Option exercise (derivative) | 49,601 | $0.00 | 0 |
| 2024-04-01 | Grant / award (derivative) | 44,246 | $0.00 | 44,246 |
| 2024-04-01 | Tax withholding | 27,755 | $249.28 | 246,693 |
| 2024-04-01 | Option exercise | 49,601 | $0.00 | 274,448 |
| 2024-04-01 | Grant / award | 15,044 | $0.00 | 261,737 |
| 2024-03-21 | Grant / award (derivative) | 49,601 | $0.00 | 49,601 |
| 2023-04-01 | Grant / award (derivative) | 55,488 | $0.00 | 55,488 |
| 2023-04-01 | Option exercise (derivative) | 110,894 | $0.00 | 0 |
| 2023-04-01 | Grant / award | 18,128 | $0.00 | 224,847 |
| 2023-04-01 | Tax withholding | 61,271 | $199.97 | 206,719 |
| 2023-04-01 | Option exercise | 110,894 | $0.00 | 267,990 |
| 2023-03-23 | Grant / award (derivative) | 110,894 | $0.00 | 110,894 |
| 2022-04-01 | Grant / award (derivative) | 51,976 | $0.00 | 51,976 |
| 2022-04-01 | Option exercise (derivative) | 75,220 | $0.00 | 0 |
| 2022-04-01 | Grant / award | 15,224 | $0.00 | 157,096 |
| 2022-04-01 | Option exercise | 75,220 | $0.00 | 183,655 |
| 2022-04-01 | Tax withholding | 41,783 | $202.40 | 141,872 |
| 2022-03-17 | Grant / award (derivative) | 75,220 | $0.00 | 75,220 |
| 2021-07-02 | Tax withholding | 22,927 | $195.71 | 108,435 |
| 2021-04-01 | Grant / award (derivative) | 51,691 | $0.00 | 51,691 |
| 2021-04-01 | Grant / award | 13,548 | $0.00 | 131,362 |
| 2020-04-01 | Grant / award (derivative) | 120,014 | $0.00 | 120,014 |
| 2020-04-01 | Grant / award | 27,724 | $0.00 | 117,814 |
| 2020-03-06 | Open-market buy | 10,000 | $103.86 | 90,090 |
| 2019-05-24 | Open-market buy | 10,000 | $95.05 | 80,090 |
| 2019-04-01 | Grant / award (derivative) | 82,460 | $0.00 | 82,460 |
| 2019-04-01 | Grant / award | 18,800 | $0.00 | 70,090 |
| 2018-07-02 | Grant / award (derivative) | 166,240 | $0.00 | 166,240 |
| 2018-07-02 | Grant / award | 51,290 | $0.00 | 51,290 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.